Ankylosing spondylitis (AS) increases the risk of various cardiac manifestations, specifically conduction disturbances, aortic regurgitation, and coronary artery disease.
| INTRODUC TI ON
Ankylosing spondylitis (AS) increases the risk of various cardiac manifestations, specifically conduction disturbances, aortic regurgitation, and coronary artery disease. 1 Although the prevalence of conduction disturbances ranges from 5% to 33%, complete atrioventricular block is quite rare. 2 There is a strong immunogenetic relationship between AS and human leukocyte antigen (HLA)-B27, which is linked to conduction disturbances and aortic regurgitation. 
| C A S E REP ORT
A 46-year-old man presented with general fatigue and dizziness on effort. Although he had chronic lumbago for 10 years, he never consulted an orthopedist. He was diagnosed with a severe conduction disturbance using an electrocardiogram ( Figure 1A ). His heart rhythm was 20-30 beats/minute with advanced and complete atrioventricular block and severe bradycardia. The serum levels of creatinine and electrolytes were within normal range and the plasma level of brain natriuretic peptide was 160 pg/mL on admission. A heart rate control therapy of a continuous isoproterenol injection was initiated on his admission day. His heart rhythm improved to Mobitz II seconddegree atrioventricular block on the following day ( Figure 1B) , and his symptoms generally resolved. Transient advanced and complete atrioventricular blocks were observed only while he was sleeping.
Ischemic heart disease was ruled out by a coronary artery angio- 
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)
were slightly elevated at 0.66 mg/dL and 26 mm/h, respectively.
Moreover, laboratory test results for HLA-B27 were positive.
F I G U R E 1
Electrocardiography showing advanced and complete atrioventricular block on the day of admission (A). The atrioventricular block spontaneously improved to a Mobitz Ⅱ second-degree atrioventricular block next day (B) and to a first-degree atrioventricular block 2 wk after initiating celecoxib therapy (C). After 3 mo, the PR interval returned to normal limits (D). The recurrence of prolonged PR interval was observed 6 mo later with the upregulated inflammatory markers (E). The paper speed of the electrocardiogram was 12.5 mm/s only in Figure 1A . The paper speed of other figures (B-E) was usual (25 mm/s)
The patient was examined in the active phase by cardiac magnetic resonance imaging when he presented with the Mobitz II second-degree atrioventricular block. Fat-suppressed T2-weighted magnetic resonance imaging showed high-intensity signals in the basal septal myocardium close to the membranous septum (white arrow) (A). Late gadolinium enhancement indicated high-intensity signals in the same area. 
| D ISCUSS I ON
We report a case of AS diagnosed by the presence of a transient reported that the prevalence of first-degree atrioventricular block in patients with AS was 4.6% and that the PR interval was independently associated with disease duration, 2 suggesting that inflammatory burden affects the conduction system. However, the PR interval was not associated with inflammatory makers (i.e., CRP and ESR) in their cross-sectional study. The invasive electrophysiological studies showed that the level of atrioventricular block with HLA-B27-associated diseases was predominantly localized in the atrioventricular node. 3 Conversely, the level of block in an acquired complete heart block is mostly below the bundle of His.
Therefore, implantation of a pacemaker should be carefully considered in patients with HLA-B27-associated diseases, although pacemaker treatment is generally indispensable for cases who present with high-grade atrioventricular block. This patient might need pacemaker implantation in the future. 
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